Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.
Reads0
Chats0
TLDR
The functional and regulatory network of SASPs toward opening up new possibilities for controlling aging and aging‐associated diseases are discussed.Abstract:
'Cellular senescence' is a state in which cells undergo irreversible cell cycle arrest in response to a variety of cellular stresses. Once cells senesce, they are strongly resistant to any mitogens, including oncogenic stimuli. Therefore, cellular senescence has been assumed to be a potent anticancer mechanism. Although irreversible cell-cycle arrest is traditionally considered the major characteristic of senescent cells, recent studies have revealed some additional functions. Most noteworthy is the increased secretion of various secretory proteins, such as inflammatory cytokines, chemokines, growth factors, and matrix metalloproteinases, into the surrounding extracellular fluid. These newly recognized senescent phenotypes, termed senescence-associated secretory phenotypes (SASPs), reportedly contribute to tumor suppression, wound healing, embryonic development, and even tumorigenesis promotion. Thus, SASPs appear to be beneficial or deleterious, depending on the biological context. Since senescent cells are known to accumulate during the aging process in vivo, it is quite possible that their accumulation in aged tissues promotes age-associated functional decline and various diseases, including cancers, at least to some extent. Here, we focus on and discuss the functional and regulatory network of SASPs toward opening up new possibilities for controlling aging and aging-associated diseases. This article is protected by copyright. All rights reserved.read more
Citations
More filters
Journal Article
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
TL;DR: Coppe et al. as mentioned in this paper showed that human cells induced to senesce by genotoxic stress secrete myriad factors associated with inflammation and malignancy, including interleukin (IL)-6 and IL-8.
Journal ArticleDOI
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.
Irene Maeve Rea,Irene Maeve Rea,Irene Maeve Rea,David Gibson,Victoria McGilligan,Susan E. McNerlan,H. Denis Alexander,Owen A. Ross,Owen A. Ross +8 more
TL;DR: Molecular pathways that appear to contribute to the immune imbalance and the cytokine dysregulation, which is associated with “inflammageing” or parainflammation are highlighted and suggested to delay age-related diseases and aging itself by suppressing pro-inflammatory molecular mechanisms or improving the timely resolution of inflammation.
Journal ArticleDOI
Cellular Senescence: Aging, Cancer, and Injury
Arianna Calcinotto,Jaskaren Kohli,Elena Zagato,Laura Pellegrini,Marco Demaria,Andrea Alimonti +5 more
TL;DR: The known key features of senescence, the cell-aut autonomous, and noncell-autonomous regulators of senescent cells are described, and the functional role of this fundamental process in different contexts is discussed in light of the development of novel therapeutic targets.
Journal ArticleDOI
Unmasking senescence: context-dependent effects of SASP in cancer
TL;DR: This Review discusses the diverse effects of senescence and thesenescence-associated secretory phenotype (SASP) on tumour growth, focusing on the functional and sometimes opposing outputs of the SASP in stromal cells and incipient tumour cells.
Journal ArticleDOI
Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Peter Thompson,Ajit Shah,Vasilis Ntranos,Vasilis Ntranos,Frédéric Van Gool,Mark A. Atkinson,Anil Bhushan +6 more
TL;DR: It is shown that during the natural history of T1D in humans and the non-obese diabetic (NOD) mouse model, a subset of beta cells acquires a senescence-associated secretory phenotype (SASP), and clearance of senescent beta cells could be a new therapeutic approach for T1d.
References
More filters
Journal ArticleDOI
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Jun Hashimoto,Patrick Garnero,Désirée van der Heijde,Nobuyuki Miyasaka,Kazuhiko Yamamoto,Shinichi Kawai,Tsutomu Takeuchi,Hideki Yoshikawa,Norihiro Nishimoto +8 more
TL;DR: Tocilizumab monotherapy is more effective in reducing radiological progression in patients presenting with risk factors for rapid progression than in low-risk patients, and patients at high risk for progression may benefit more from tocilizumAB treatment.
Journal ArticleDOI
Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells
Francesco Prattichizzo,Angelica Giuliani,Rina Recchioni,Massimiliano Bonafè,Fiorella Marcheselli,Sabrina De Carolis,Anna Campanati,Katia Giuliodori,Maria Rita Rippo,Francesca Brugè,Luca Tiano,Carla Micucci,Antonio Ceriello,Annamaria Offidani,Antonio Domenico Procopio,Fabiola Olivieri +15 more
TL;DR: The findings suggest that adalimumab can induce epigenetic modifications in cells undergoing senescence, thus contributing to the attenuation of SASP tumor-promoting effects.
Journal ArticleDOI
Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells.
Gyeong In Mun,Yong Chool Boo +1 more
TL;DR: CD44 and other senescence-induced cell adhesion genes identified in this study may provide the novel targets for the prevention of inflammatory leukocyte adhesion leading to the development atherosclerosis.
Journal Article
Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan.
Hidetoshi Tahara,K. Kamada,E. Sato,Naohiro Tsuyama,Jin-Kyeoung Kim,E. Hara,K. Oda,Toshinori Ide +7 more
TL;DR: The results suggest that normal and SV40-transformed human fibroblasts increase expression of IFN-beta with increasing proliferative age especially near the end of their lifespan resulting in induction ofIFN-inducible genes and possibly in growth repression.
Journal ArticleDOI
Age-related changes in collagenase expression in cultured embryonic and fetal human skin fibroblasts.
TL;DR: Data suggest that decreased in vitro expression is correlated with decreased levels of translatable collagenase mRNA but that other factors, such as the collagenase inhibitor and altered specific activity of the enzyme, may be important in modulating collagenase activity.